Adjuvanted inactivated rabies virus-vectored Lassa virus vaccine in healthy adults: a phase 1 trial - Top-Institutions - MDSpire

Adjuvanted inactivated rabies virus-vectored Lassa virus vaccine in healthy adults: a phase 1 trial

  • By

  • Justin R. Ortiz

  • Drishya Kurup

  • Adam C. Kaufman

  • Sabrine Ben Hamed

  • Allison M. LaRocco

  • Kirsten E. Lyke

  • Sarah M. Litts

  • Shrimati Datta

  • Yuanyuan Liang

  • Megan F. McGilvray

  • Jeannie A. Losignor

  • Jennifer J. Oshinsky

  • Kari V. Palmer

  • Ifayet PL Johnson-Mayo

  • Gabrielle Scher

  • Uthra Balakumar

  • Anisha Chandwani

  • Rekha R. Rapaka

  • Meagan E. Deming

  • Joel V. Chua

  • Christoph Wirblich

  • Wilbur H. Chen

  • Kathleen M. Neuzil

  • Marcela F. Pasetti

  • Matthias J. Schnell

  • June 9, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Thomas Jefferson University
    Thomas Jefferson University

    Philadelphia, PA

    Key Differentiators

    • Infectious Disease
  • #2

    University of Maryland School of Medicine’s Center for Vaccine Development and Global Health
    University of Maryland School of Medicine’s Center for Vaccine Development and Global Health

    Baltimore, MD

    Key Differentiators

    • Infectious Disease

Original Source(s)

Related Content